Display Settings:

Format

Send to:

Choose Destination
FEBS Lett. 2008 Jan 9;582(1):97-105. Epub 2007 Nov 29.

Inflammation and insulin resistance.

Author information

  • 1University of California at San Diego, Department of Medicine (0673), 225 Stein Clinical Research Building, 9500 Gilman Drive, La Jolla, CA 92093, USA.

Abstract

Obesity-induced chronic inflammation is a key component in the pathogenesis of insulin resistance and the Metabolic syndrome. In this review, we focus on the interconnection between obesity, inflammation and insulin resistance. Pro-inflammatory cytokines can cause insulin resistance in adipose tissue, skeletal muscle and liver by inhibiting insulin signal transduction. The sources of cytokines in insulin resistant states are the insulin target tissue themselves, primarily fat and liver, but to a larger extent the activated tissue resident macrophages. While the initiating factors of this inflammatory response remain to be fully determined, chronic inflammation in these tissues could cause localized insulin resistance via autocrine/paracrine cytokine signaling and systemic insulin resistance via endocrine cytokine signaling all of which contribute to the abnormal metabolic state.

PMID:
18053812
[PubMed - indexed for MEDLINE]
PMCID:
PMC2246086
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk